[1] McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis[J]. Am J Pathol,1969,56(1):111-128.
[2] Chen S, Guo X, Dong S, et al.Relationship between lifestyle factors and hyperhomocysteinemia in general Chinese population: a cross-sectional study[J]. Postgrad Med,2017,129(2):216-223.
[3] Kundi H, Kiziltunc E, Ates I, et al.Association between plasma homocysteine levels and end-organ damage in newly diagnosed type 2 diabetes mellitus patients[J]. Endocr Res,2017,42(1):36-41.
[4] Wang Y, Chen S, Yao T, et al.Homocysteine as a risk factor for hypertension: a 2-year follow-up study[J]. PLoS One,2014,9(10):e108223.
[5] White W, Brost B, Garovic V, et al.History of hypertension in pregnancy predicts hyperhomocysteinemia decades later[J]. Am J Obstet Gynecol,2011,204:S312-S312.
[6] Muthuramu I, Singh N, Amin R, et al.Selective homocysteine-lowering gene transfer attenuates pressure overload-induced cardiomyopathy via reduced oxidative stress[J]. J Mol Med (Berl),2015,93(6):609-618.
[7] 陈梅, 罗莉芸, 陈健珍, 等. 高血压和脑动脉硬化症与血清同型半胱氨酸浓度变化相关性分析[J]. 实验与检验医学,2016,34(3):371-373.
[8] Han L, Wu Q, Wang C, et al. Homocysteine, Ischemic Stroke,Coronary Heart Disease in Hypertensive Patients: A Population-Based, Prospective Cohort Study[J]. Stroke,2015 Jul,46(7):1777-1786.
[9] Gopinath B, Flood VM, Rochtchina E, et al.Serum homocysteine and folate but not vitamin B12 are predictors of CHD mortality in older adults[J]. Eur J Prev Cardiol,2012,19(6):1420-1429.
[10] Han L, Liu Y, Wang C, et al.Determinants of hyperhomocysteinemia in healthy and hypertensive subjects: A population-based study and systematic review[J]. Clin Nutr,2017,36(5):1215-1230.
[11] Ma Y, Peng D, Liu C, et al.Serum high concentrations of homocysteine and low levels of folic acid and vitamin B12 are significantly correlated with the categories of coronary artery diseases[J]. BMC Cardiovasc Disord,2017, 17(1):37.
[12] Masud R, Baqai HZ.The communal relation of MTHFR, MTR, ACE gene polymorphisms and hyperhomocysteinemia as conceivable risk of coronary artery disease[J]. Appl Physiol Nutr Metab,2017,42(10):1009-1014.
[13] McCarty MF, O'Keefe JH, DiNicolantonio JJ. Interleukin-1beta may act on hepatocytes to boost plasma homocysteine-The increased cardiovascular risk associated with elevated homocysteine may be mediated by this cytokine[J]. Med Hypotheses,2017,102:78-81.
[14] Huang X, Lv X, Song H, et al.The relationship between S-adenosylhomocysteine and coronary artery lesions: A case control study[J]. Clin Chim Acta,2017,471:314-320.
[15] Li Y, Huang T, Zheng Y, et al.Folic Acid Supplementation and the Risk of Cardiovascular Diseases: A Meta-Analysis of Randomized Controlled Trials[J]. J Am Heart Assoc,2016,5(8):e003768.
[16] Alter P, Rupp H, Rominger MB, et al.Association of hyperhomocysteinemia with left ventricular dilatation and mass in human heart[J]. Clin Chem Lab Med,2010,48(4):555-560.
[17] Rodriguez WE, Tyagi N, Joshua IG, et al.Pioglitazone mitigates renal glomerular vascular changes in high-fat, high-calorie-induced type 2 diabetes mellitus[J]. Am J Physiol Renal Physiol,2006,291(3):F694-F701.
[18] Mao S, Xiang W, Huang S, et al.Association between homocysteine status and the risk of nephropathy in type 2 diabetes mellitus[J]. Clin Chim Acta,2014,431:206-210.
[19] Wang H, Cui K, Xu K, et al.Association between plasma homocysteine and progression of early nephropathy in type 2 diabetic patients[J]. Int J Clin Exp Med,2015,8(7):11174-11180.
[20] 张梅, 胡大春, 赵晓丽, 等. 高同型半胱氨酸血症对2型糖尿病患者血糖控制的影响[J]. 昆明医科大学学报,2016,37(4):62-64.
[21] Sudchada P, Saokaew S, Sridetch S, et al.Effect of folic acid supplementation on plasma total homocysteine levels and glycemic control in patients with type 2 diabetes: a systematic review and meta-analysis[J]. Diabetes Res Clin Pract,2012,98(1):151-158.
[22] Li JG, Barrero C, Merali S, et al.Five lipoxygenase hypomethylation mediates the homocysteine effect on Alzheimer's phenotype[J]. Sci Rep,2017,7:46002.
[23] McCaddon A, Davies G, Hudson P, et al. Total serum homocysteine in senile dementia of Alzheimer type[J]. Int J Geriatr Psychiatry,1998,13(4):235-239.
[24] McIlroy SP, Dynan KB, Lawson JT, et al. Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland[J]. Stroke, 2002,33(10):2351-2356.
[25] Schafer JH, Glass TA, Bolla KI, et al.Homocysteine and cognitive function in a population-based study of older adults[J]. J Am Geriatr Soc,2005,53(3):381-388.
[26] Smith AD, Smith SM, de Jager CA, et al. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial[J]. PLoS One,2010,5(9): e12244.
[27] Zheng L, Kong X, Cui Y, et al.Conversion from MCI to AD in patients with the APOE ε4 genotype: Prediction by plasma HCY and serum BDNF[J]. Neurosci Lett,2016, 626:19-24.
[28] Hu Q, Teng W, Li J, et al.Homocysteine and Alzheimer's Disease: Evidence for a Causal Link from Mendelian Randomization[J]. J Alzheimers Dis,2016,52(2):747-756.
[29] Aisen PS, Schneider LS, Sano M,et al.High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial[J]. JAMA, 2008, 300(15):1774-1783.
[30] McCaddon A, Miller JW. Assessing the association between homocysteine and cognition: reflections on Bradford Hill, meta-analyses, and causality[J]. Nutr Rev, 2015, 73(10):723-735.
[31] Rajagopalan P, Hua X, Toga AW, et al.Homocysteine effects on brain volumes mapped in 732 elderly indivi-duals[J]. Neuroreport,2011,22(8):391-395. |
